2024-516265-37-00已完成1 期
INTERACT stomach
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)2 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2024年8月6日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 54
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Coordinating investigator, N Guchelaar
Scientific
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
1 期
INTERACT stomachStomach Cancer with metastasis in the peritoneumCTIS2024-516265-37-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)54
尚未招募
不适用
AUGMENTED RESPONSE OF VOLATILE BIOMARKERS IN THE ASSESSMENT OF OESOPHAGOGASTRIC CANCER (AROMA2)NCT07260734Imperial College London6,000
招募中
1 期
A Study to Understand What the Body Does to the Study Medicine Called PF-07976016 When Taken by Healthy AdultsObesity2024-518535-11-00Pfizer Inc.8
招募中
1 期
A Study to Test How Safe, Effective and How Body’s Responds to the Combination of Mosunetuzumab and Pirtobrutinib Together to Treat Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia2024-514152-32-00F. Hoffmann-La Roche AG22
已完成
1 期
This is clinical study to test, for the first time in people, the safety (any
good or bad effects), how long the drug can stay in the body and if it can
control the disease of people diagnosed with advanced cancer that has not
responded to treatment, has returned after it has been treated, or cannot
be treated by surgery, drugs, or any other known treatments.2023-509969-20-00Celgene Corp.127